Caplyta 21 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM1FY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,538
Award facts
- Contract value 100% obligated
- $10,537.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,537.51 to AmerisourceBergen Drug Corp for CAPLYTA 21 mg capsules (30-count supply) on December 26, 2025, with completion scheduled for December 29, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to meet DoD procurement requirements through open competition, with previous awards covering diabetes medications, neurological treatments, pain management pharmaceuticals, and other specialty medications. The SPE2DX prime vendor contract enables AmerisourceBergen to provide pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning to establish multiple regional Pharmaceutical Prime Vendor Global Program Generation V contracts involving at least three contractors going forward.
Quick answers
Who was awarded contract SPE2DR26FM1FY?
SPE2DR26FM1FY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DR26FM1FY worth?
The government has obligated $10,538 on SPE2DR26FM1FY.
Is contract SPE2DR26FM1FY an order under another contract?
Yes. SPE2DR26FM1FY is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1FY competed?
The extent of competition for SPE2DR26FM1FY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award